Post COVID-19 Organizing Pneumonia: A Systematic Review and Meta-analysis

Talal Khalid Abdullah Alanazi *

Internal medicine resident, Tabuk, Saudi Arabia.

Nasser Faris Ali Alahmari

Internal medicine resident, Tabuk, Saudi Arabia.

Faris Essa Ibrahim Qubays

Internal medicine resident, Tabuk, Saudi Arabia.

Solaiman Hosaian ibraheem Alenezi

Internal medicine resident, Tabuk, Saudi Arabia.

Meshal Faleh Mofadhe Alenezi

Internal medicine resident, Tabuk, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Several observational studies have found parallels between COVID-19 pneumonia and organizing pneumonia (OP). This study aims to investigate the published literature of OP related to COVID-19, estimates the prevalence of OP among COVID-19 patients, and assesses the risk or COVID-19 severity associated with OP.

Methodology: This was a systematic review and meta-analysis. A systematic electronic search through PubMed, Web of Science, Science Direct, EBSCO, and Google Scholar was conducted to include relevant and eligible literature. The authors used Review Manager 5.4 to perform quantitative data synthesis for the condition of interest analyses.

Results: A total of 9 eligible study articles and 12 case reports were included in this study. The estimated pooled organizing pneumonia prevalence among COVID-19 patients was 45.6% [23.1%-68.2%]. The association between OP and severe COVID-19 infection revealed a pooled OR [95% CI] of 5.22 [-0.96-11.41].

Conclusion: COVID-19 patients had a rather high OP prevalence (43%). Surprisingly, cancer patients with COVID-19 infection had the lowest OP prevalence. OP was identified as a possible risk factor for the severity of COVID-19 infection.

Keywords: COVID-19, organizing pneumonia, secondary organizing pneumonia


How to Cite

Alanazi, Talal Khalid Abdullah, Nasser Faris Ali Alahmari, Faris Essa Ibrahim Qubays, Solaiman Hosaian ibraheem Alenezi, and Meshal Faleh Mofadhe Alenezi. 2021. “Post COVID-19 Organizing Pneumonia: A Systematic Review and Meta-Analysis”. Journal of Pharmaceutical Research International 33 (38B):259-70. https://doi.org/10.9734/jpri/2021/v33i38B32122.

Downloads

Download data is not yet available.